The determination of the value of the no-observed-adverse-effect level (NOAEL) when observed responses can be categorized by severity (categorical data) and sample sizes are small is discussed. The common situation of only two categories, where only the presence or absence of an effect is observed, is addressed first (dichotomous data). Three tests for dichotomous data are critically examined, including the Brown-La Hnge test, a modified version ofthat test, and Dunnett's multiple comparison test. Although the modified test is an improvement, all three procedures have shortcomings in determining the value ofthe NOAEL, particularly whenthe sample size is small. An alternative method is suggested, based on the Akaike information criterion (AIC), which performs well. This method is extended to severity data with an arbitrary number of categories. Use of a dose-response curve for the NOAEL is discussed.
Introduction
As used here, the no-observed-adverse-effect level (NOAEL) is the highest experimental dose at which there is no statistically significant increase in an adverse toxicological end point. This definition restricts the possible values of the NOAEL to the experimental dose values, the only dose levels at which there are observations. Sometimes a dose-response curve is fit to the data, which provides a way of estimating the NOAEL as the lowest dose corresponding to the point on the curve at which the predicted response equals the control rate plus a specified value equal to an acceptable level ofincreased risk. At low-dose levels, the NOAEL dose may be sensitive to the choice of the doseresponse curve fit to the data, particularly in small samples. Consequently, this approach has been suggested for determining the "benchmark dose" as an alternative to the NOAEL, a lower confidence limit to a dose producing some predetermined increase in response rate that will not involve extrapolation far below the experimental range (1) . The concept ofthe NOAEL is central to assessment of risk from systematic toxicants, as currently practiced. Inclusion of the NOAEL value in reported laboratory experiments is recommended by the Pharmaceutical Affairs Bureau, Japanese government (GLP, 1989) . The U.S. Environmental Protection Agency (EPA) uses the NOAEL in setting ' Department of Mathematics, Kyushu University, Fukuoka 812, Japan. 2Sasebo College of Technology, Sasebo 857-11, Japan. 3Kenneth G. Brown Inc., P.O. Box 16608, Chapel Hill, NC 27516-6608. statistical approach that may be used fot the NOAEL is to test the hypothesis ofno difference in the true response rates between the control group and a treatment group, pairing the control group for a test with each treatment group sequentially. Williams' test functions this way and can be applied when the data are assumed to be sampled from a normal distribution, e.g., when response is weight gain (4) . A nonparametric version of that test for use when data are from a continuous but non-normal distribution is described by Shirley (5) and Williams (6) . These tests are order restricted, incorporating a prior knowledge that the expected response does not decrease (or increase) as dose level increases. We are unaware of any test in this class for categorical data applicable when severity of response is recorded. For simple dichotomous data (two categories), the test ofBrown-La Vange (7) and a modified version of that test described here are examples of order-restricted conditional tests. For dichotomous responses, considerable attention has been focused on applying dose-response curves for both cancer and noncancer responses.
Crump (1) essentially converted his multistage model for cancer data to noncancer application by adding a parameter for a "threshold" dose.
In this paper we are interested in the NOAEL for categorical data, including dichotomous data as a simple case (k=2), from the statistical point ofview. Issues related to regulatory applications, such as the use of safety factors with the NOAEL, are not discussed. We study first the behavior of three tests with dichotomous data, including the Brown (2) underpo = pi = P2, from which the NOAEL is determined according to: if t, 2 k, then NOAEL = do; if t, < k and t2 > k, then NOAEL = di; if t, < k and t2 < k, then NOAEL = d2.
Modification to the Brown-La Vange Test
This test pools the responses at do and di, if no significance difference is detected between these dose levels to increase the power of the test. The test is based on the values of (ro, r,,... ,rk), the naive responses. The test procedure is the same as that of the Brown-La Vange test except the test statistic. The test statistic fbr H0' is u, = rI/nI -ro/no, and the test statistic for H02 is U2 = r2/n2 -(r + r1)/(no + n,). For a specified test size, Of,, the test rejects H0' if u, 2 k,*, where k, is the smallest constant such that Pr[ u, 2 k,*I S(r) ] . a,, when H0' is true. For a specified test size, C2, the test rejects H02 if U2 2 k2*, where k2* is the smallest constant such that Pr(u2 2 k2 I S(r), ul < kj ) < al (3) under H02.
Small-Sample Behavior of the Tests
We compare the tests in detail when k = 2, no=n=n2=10, and S(r)=4. When S(r)=4 is given, the number of all possible configurations of the tables of no =n, =n2 =10 is 15, as shown in Table 1 . The probability of each entry in the table, when Po=PI =P2, has been computed from a multiple hypergeometric distribution and included in the table. Consequently, the probability is the chance occurrence ofan entry in the absence ofan effect.
The distributions of statistics t, and u, have been tabulated from the entries in Table 1 and are displayed in Table 2 . Table 2 shows that, in the case of the conditional test based on the adjusted response, the values of the test statistic t, take only four points with positive probability, and thejumps ofthe cumulative Table 1 . List of all feasible tables when no =n, =n2=10 and S)r) = 4.
Entry Number  Response  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15   ro   0  0  0  0  0  1  1  1  1  2  2  2  3  3 The three tests are applied to each entry in Table 1 with the results summarized in Table 3 . When entry no. 4 or 5 is observed (Table 1) , the modified test selects do as the NOAEL at the test size a, = 0.10 and a2 = 0.1004; when entry no. 1, 2, or 6 is observed (Table 1) , then d, is selected as the NOAEL; and when any other number is observed, d2 is selected as the NOAEL. The probabilities of the correct decision for MBLV under Po = pI. P2 (case 2) and po p, = p2(case 3) may be computed using the formula P(ui< kj, u2.> k I S(r)) = PrKu1 < k; I S(r) )P~u2 > 41; S(r), ul < kl ) (4) by specifying the values ofpo and the values ofthe added risk2 -po. Figure 1 shows With small sample sizes, however, the probability ofthe correct decision in case 3 is disappointingly small. e) A puzzling aspect of the modified test may be noted. Suppose that entry no. 4 in Table 4 is observed. Ifwe set a, = 0.05 and a2 = 0.10, then 
Application of the AIC
We continue with the same notation and conditions described in the previous sections, i.e., k =2 with dichotomous data. Let YIP= log1( )Po)), Y2 =10g(P2(l PO.) ( -PI )Po (-P2 )Po (5) The parameters oy and 'y2 are the log odds ratios ofthe effect at diand d2, respectively, relative to the effect at do. The conditional log likelihood conditioned on S(r) = (ro+rl +r2) is l(I ry2)= const + yi r I+72 r2, log I , X2( ) (ni-xi , n -x2) exp(rI xl + rt X2), (6) were Is X X!X xl ,x2} (S-XI -x2 ) !. xI ! x2 ! (7) and E* is the summation that extends over all integers xi and x2 suchthatni . This procedure is applied to the entries in Table 1 . The results are given in the last row ofTable 3. Figure 2 illustrates the probability of the correct decision for case 2 and for case 3. Comparing these results with the outcomes ofthe preceding tests, one can clearly see the superiority ofthis method. In particular, the AIC method relieves the problem of selecting the test size described earlier and increases the probability of a correct decision. The model (8) , which seems somewhat artificial, is a mathematical device to lead to this reasonable result. The order restriction is represented by -yj 2 0, and yi -yi-, 2 0, i = 2,3,... ,k. The AIC is applied for the determination ofthe NOAEL taking this restriction into account. for k = 2, the procedure is the same as that given in the preceding section. We also extended the modified test (MBLV) to apply to these data for comparison. The test leads to d2 as the NOAEL for caI = 0.10 and Ci2 = 0.10. The dose-response curve method is also , 02) is known, the estimate of f% from the full likelihood is -3.0132. Alternatively, the estimate of O% from the control group data alone is -2.8898. Figure 3 shows the average doseresponse curve and its upper 95 % confidence bound. we may assess the NOAEL from Figure 3 . For example, when c = 0.2 is specified in the relative risk model, the NOAEL is assessed to be 0.85. 
Discussion
We have developed several methods of selecting the NOAEL when the responses are measured by severity and also when the sample sizes are small. Our conclusions are as follows: a) Ifone wants to select the NOAEL from the experimental dose levels I d0,dl,.. . ,dk ), then implementation of the AIC in the order restricted likelihood method is preferable to a testing approach, as demonstrated for three alternative test procedures. b) If one wants to select the NOAEL from the full experimental range of doses, (do to dk), then a dose-response curve is required to estimate responses between observed values. The choice of the dose-response curve may affect the outcome, but fitting the "average dose-response curve" as described is reasonable. The choice of c in that model should be chosen carefully. The NOAEL can be based on either relative risk or additive risk, depending on one's objective.
